By: Carl Schwartzbaum In a major leap forward for both obesity treatment and cancer prevention, new research out of Israel reveals that GLP-1 receptor agonist (GLP-1RA) drugs — such as Saxenda, Trulicity, and Byetta — may slash the risk of obesity-related cancers more effectively than bariatric surgery. As reported by The New York Post, the […]
